Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices? The iShares U.S. Pharmaceutic...
Topics
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices? The iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) is the rare fund that has spent the past year being publicly threatened by the President of the United States and quietly outperforming nearly every healthcare benchmark anyway.
Related QATS news
- HARD: A No K-1 Commodity Strategy ETF The Simplify Commodities Strategy No K-1 ETF is rated a buy, ...
- Utilities ETF FXU Hits 17% Annual Gain As Data Centers Reshape Power Demand Data center electricity...
- Most Income Investors Have Never Heard of These 3 ETFs. One Pays 14% Monthly Income investors have ...
- ETF Prime Podcast: Why Free Cash Flow Is Where Quality Begins “Quality” has become a pervasive buzz...